iShares Biotechnology ETF

IBB

iShares Biotechnology ETF IBB Strategy

The investment seeks to track the investment results of the NYSE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.

ETFs News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,646.9015.400.18%
CAC 407,826.791.34-0.02%
DAX 4024,226.49198.840.83%
Dow JONES (US)42,343.65740.581.78%
FTSE 1008,778.0560.080.69%
HKSE23,381.9999.660.43%
NASDAQ19,199.16461.962.47%
Nikkei 22538,087.04362.930.96%
NZX 50 Index12,485.9896.35-0.77%
S&P 5005,921.54118.722.05%
S&P/ASX 2008,421.6014.000.17%
SSE Composite Index3,340.696.15-0.18%

Market Movers